SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-17-011114
Filing Date
2017-06-12
Accepted
2017-06-12 07:03:58
Documents
19

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 plxp20170516_424b5.htm 424B5 1423176
2 mucinexslide.jpg GRAPHIC 105132
3 image17.jpg GRAPHIC 20261
4 image16.jpg GRAPHIC 13955
5 image15.jpg GRAPHIC 15307
6 image14.jpg GRAPHIC 16822
7 image13.jpg GRAPHIC 14705
8 image12.jpg GRAPHIC 19298
9 image11.jpg GRAPHIC 63470
10 image10.jpg GRAPHIC 11629
11 image9.jpg GRAPHIC 57879
12 image8.jpg GRAPHIC 44796
13 image7.jpg GRAPHIC 58235
14 image6.jpg GRAPHIC 68497
15 image5.jpg GRAPHIC 24387
16 image4.jpg GRAPHIC 35243
17 image3.jpg GRAPHIC 78336
18 image2.jpg GRAPHIC 83581
19 image1.jpg GRAPHIC 7670
  Complete submission text file 0001437749-17-011114.txt   2444258
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-204830 | Film No.: 17904568
SIC: 2834 Pharmaceutical Preparations